Advertisement

How Safe is the Blood Supply in the United States?

  • Roger Y. Dodd

Abstract

It has long been known that transfusion of blood or its derivatives may also result in the inadvertent transmission of infectious agents, particularly those associated with a silent carrier state. For many years, hepatitis and syphilis were the only diseases which were recognized as transmissible by this route, but there appeared to be relatively little anxiety among the general public. The recognition of AIDS among recipients of clotting factor concentrates and single donor transfusions was, in contrast, widely publicised and led to considerable and continuing concern. Indeed, the association between blood transfusion and AIDS became so firm that a significant proportion of the population mistakenly believed that AIDS could be contracted as a result of giving blood. The need to reduce transfusion associated AIDS led to a new and more intensive focus on the whole issue of the safety of the blood supply. In fact, in the three years following the introduction of HIV antibody screening, three additional tests were implemented by blood collection agencies as measures to reduce the transmission of other viruses. In addition, there have been demonstrable improvements in the methods used to screen the donor population and there is real hope that inactivation of viral or microbial contaminants in cellular blood products will be achieved. It will be shown that the chance of being infected by blood transfusion has never been lower than it is now. Finally, physicians have recognized the need to review the risks and benefits of every transfusion and to seek safe alternatives wherever possible.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Acquire Immune Deficiency Syndrome Blood Unit Donor Population 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aach, R.D., W. Szmuness, J.W. Mosley, F.B. Hollinger, R.A. Kahn, C.E. Stevens, V.M. Edwards, and J. Werch. 1981. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The Transfusion-Transmitted Viruses Study. N Eng J Med 304:989–994.CrossRefGoogle Scholar
  2. 2.
    Ablashi, D.V., S.Z. Salahuddin, S.F. Josephs, F. Imam, P. Lusso, R.C. Gallo, C. Hung, J. Lemp, and P.D. Markham. 1987. HBLV (or HHV-6) in human cell lines. Nature 329:207–207.PubMedCrossRefGoogle Scholar
  3. 3.
    Allain, J.-P., Y. Laurian, D.A. Paul, D. Senn, and Members of the AIDS-Haemophilia French Study Group. 1986. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet 2:1233–1236.PubMedCrossRefGoogle Scholar
  4. 4.
    Allen, J.G. 1972. The epidemiology of posttransfusion hepatitis. Basic blood and plasma tabulations. p.1-335. Commonwealth Fund, Stanford.Google Scholar
  5. 5.
    Alter, H.J., R.H. Purcell, P.V. Holland, D.W. Ailing, and D.E. Koziol. 1981. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 246:630–634.PubMedCrossRefGoogle Scholar
  6. 6.
    Alter, M.J., A. Mares, S.C. Hadler, and J.E. Maynard. 1987. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Amer J of Epid 125:133–139.Google Scholar
  7. 7.
    Anderson, M.J. 1987. Human parvovirus infections. J of Vir Meth 17:175–181.CrossRefGoogle Scholar
  8. 8.
    Aubuchon, J.A., and R.Y. Dodd. 1988. Analysis of the relative safety of autologous blood units available for transfusion to homologous recipients. Transfusion 28:403–405.PubMedCrossRefGoogle Scholar
  9. 9.
    Azimi, P.H., R.R. Roberto, J. Guralnick, T. Livermore, S. Hoag, S. Hagens, and N. Lugo. 1986. Transfusion-acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery. Amer J Dis Children 140:23–27.Google Scholar
  10. 10.
    Backer, U., F. Weinauer, G. Gathof, and J. Eberle. 1987. HIV antigen screening in blood donors [letter]. Lancet 2:1213–1214.PubMedCrossRefGoogle Scholar
  11. 11.
    Baker, J.L., G.D. Kelen, K.T. Sivertson, and T.C. Quinn. 1987. Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA 257:2609–2611.PubMedCrossRefGoogle Scholar
  12. 12.
    Barre-Sinoussi, F., J.-C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Brun-Vezinet, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871.PubMedCrossRefGoogle Scholar
  13. 13.
    Berman, M., A.J. Alter, K.G. Ishak, R.H. Purcell, and A.E. Jones. 1979. The chronic sequelae of non-A, non-B hepatitis. Ann of Intern Med 91:1–6.Google Scholar
  14. 14.
    Blattner, W.A., D.W. Blayney, MR. Guroff, M.G. Sarngadharan, V.S. Kalyanaraman, P.S. Sarin, E.S. Jaffe, and R.C. Gallo. 1983. Epidemiology of Human T-Cell Leukemia/Lymphoma Virus. J of Inf Dis 147:406–416.CrossRefGoogle Scholar
  15. 15.
    Bradley, D.W., J.E. Maynard, H. Popper, E.H. Cook, J.W. Ebert, K.A. McCaustland, C.A. Schable, and H.A. Fields. 1983. Posttransfusion non-A, non-B hepatitis: Physicochemical properties of two distinct agents. J of Inf Dis 148:254–265.CrossRefGoogle Scholar
  16. 16.
    Braine, H.G., T.S. Kickler, P. Charache, P.M. Ness, J. Davis, C. Reichart, and A.K. Fuller. 1986. Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature. Transfusion 26:391–393.PubMedCrossRefGoogle Scholar
  17. 17.
    Burke, D.S., B.L. Brandt, R.R. Redfield, T.H. Lee, R.M Thorn, G.A. Beltz, and C.H. Hung. 1987. Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide. Comparison to Western blot on 2707 consecutive serum samples. Ann Intern. Med 106:671–676.PubMedGoogle Scholar
  18. 18.
    Burke, D.S., J.F. Brundage, J.R. Herbold, W. Berner, L.I. Gardner, J.D. Gunzenhauser, J. Voskovitch, and R.R. Redfield. 1987. Human immunodeficiency virus infections among civilian applicants for United States military service, October 1985 to March 1986. Demographic factors associated with seropositivity. N Eng J Med 317:131–136.CrossRefGoogle Scholar
  19. 19.
    Carlson, J.R. 1988. Serological diagnosis of human immunodeficiency virus infection by Western blot testing. JAMA 260:674–679.CrossRefGoogle Scholar
  20. 20.
    Carlson, J.R., J. Yee, S.H. Hinrichs, ML. Bryant, MB. Gardner, and N.C. Pedersen. 1987. Comparison of indirect immunofluorescence and Western blot for detection of anti-human immunodeficiency virus antibodies. J Clin. Microbiol 25:494–497.PubMedGoogle Scholar
  21. 21.
    CDC 1987. Human immunodeficiency virus infection in the United States: A review of current knowledge. MMWR 26(Supplement S6):1–48.Google Scholar
  22. 22.
    CDC 1988. Licensure of screening tests for antibody to human T-lymphotropic virus type I. MMWR 37:736–745.Google Scholar
  23. 23.
    CDC 1988. Yersinia enterocolitica bacteremia and endotoxin shock associated with red blood cell transfusion-United States, 1987–1988. MMWR 37:577–578.Google Scholar
  24. 24.
    CDC 1988. Safety of therapeutic products used for hemophilia patients. MMWR 37:441–450.Google Scholar
  25. 25.
    CDC 1989. Risks associated with human parvovirus B19 infection. MMWR 38:81–97.Google Scholar
  26. 26.
    Curran, J.W., H.W. Jaffe, A.M Hardy, W.M Morgan, R.M. Selik, and T.J. Dondero. 1988. Epidemiology of HIV infection and AIDS in the United States. Science 239:610–616.PubMedCrossRefGoogle Scholar
  27. 27.
    Dienstag, J.L. 1983. Non-A, non-B hepatitis. II. Experimental transmission, putatitve virus agents and markers, and prevention. Gastroenterol 85:743–768.Google Scholar
  28. 28.
    Dienstag, J.L. 1983. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterol 85:439–462.Google Scholar
  29. 29.
    Dock, N.L., H.V. Lamberson, Jr., T.A. O’Brien, D.E. Tribe, S.S. Alexander, and B.J. Poiesz. 1988. Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors. Transfusion 28:412–418.PubMedCrossRefGoogle Scholar
  30. 30.
    Dodd, R.Y. 1985. Donor screening and epidemiology, p.389–405. In R.Y. Dodd, and L.F. Barker (eds.), Infection, Immunity, and Blood Transfusion. Alan R. Liss, New York.Google Scholar
  31. 31.
    Dodd, R.Y., and N. Nath. 1987. Increased risk for lethal forms of liver disease among HBsAg-positive blood donors in the U.S. J of Vir Meth 17:81–94.CrossRefGoogle Scholar
  32. 32.
    Farzadegan, H., M.A. Polis, S.M Wolinsky, C.R. Rinaldo, J.J. Sninsky, S. Kwok, R.L. Griffith, R.A. Kaslow, J.P. Phair, F. Polk, and A.J. Saah. 1988. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. Ann of Intern Med 108:785–790.Google Scholar
  33. 33.
    Gallo, R.C., S.Z. Salahuddin, M Popovic, G.M Shearer, M Kaplan, B.F. Haynes, T.J. Palker, R. Redfield, J. Oleske, B. Safai, G. White, P. Foster, and P.D. Markham. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500–503.PubMedCrossRefGoogle Scholar
  34. 34.
    Gomperts, E.D. 1986. Procedures for the inactivation of viruses in clotting factor concentrates. Am J Hematol. 23:295–305.PubMedCrossRefGoogle Scholar
  35. 35.
    Goudsmit, J., F. DeWolf, D.A. Paul, L.G. Epstein, J.MA. Lange, W.J.A. Krone, H. Speelman, E.G. Wolters, J. van der Noorda, J.M Oleske, H.J. van der Helm, and R.A. Coutinho. 1986. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 2:177–180.PubMedCrossRefGoogle Scholar
  36. 36.
    Grindon, A.J., S.E. Critchley, and J.W. Ward. 1988. Risk of HIV infection in recipients of untested blood from donors now anti-HIV-positive. Transfusion 28:419–421.PubMedCrossRefGoogle Scholar
  37. 37.
    Handsfield, H.H., M Wandell, L. Goldstein, and K. Shriver. 1987. Screening and diagnostic performance of enzyme immunoassay for antibody to lymphadenopathy-associated virus. J. Clin. Microbiol. 25:879–884.PubMedGoogle Scholar
  38. 38.
    Heal, J.M., ME. Jones, J. Forey, A. Chaudry, and R.L. Stricoff. 1987. Fatal Salmonella septicemia after platelet transfusion. Transfusion 27:2–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Henle, W., and G. Henle. 1985. Epstein-Barr virus and blood transfusions, p. 201–209. In R.Y. Dodd, and L.F. Barker (eds.), Infection, Immunity, and Blood Transfusion. Alan R. Liss, New York.Google Scholar
  40. 40.
    Hoff, R., V.P. Berardi, B.J. Weiblen, L. Mahoney-Trout, ML. Mitchell, and G.F. Grady. 1988. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N. Engl. J Med. 318:525–530.PubMedCrossRefGoogle Scholar
  41. 41.
    Holland, P.V. 1988. Why a new standard to prevent Creutzfeldt-Jakob disease. Transfusion 28:293–294.PubMedCrossRefGoogle Scholar
  42. 42.
    Hollinger, F.B., N.C. Khan, P.E. Oefinger, D.H. Yawn, A.C. Schmulen, G.R. Dreesman, and J.L. Melnick. 1983. Posttransfusion hepatitis type A. JAMA 250:2313–2317.PubMedCrossRefGoogle Scholar
  43. 43.
    Kleinman, S., and K. Secord. 1988. Risk of human immonodeficiency virus (HIV) transmission by anti-HIV negative blood. Estimates using the lookback methodology. Transfusion 28:499–501.PubMedCrossRefGoogle Scholar
  44. 44.
    Koziol, D.E., P.V. Holland, D.W. Ailing, J.C. Melpolder, R.E. Solomon, R.H. Purcell, L.M. Hudson, F.J. Shoup, H. Krakauer, and H.J. Alter. 1986. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann of Intern Med 104:488–495.Google Scholar
  45. 45.
    Kuhnl, P., S. Seidl, and G. Holzberger. 1985. HLA Dr4 antibodies cause positive HTLV III antibody ELISA results. Lancet 1:1222–1223.PubMedCrossRefGoogle Scholar
  46. 46.
    Kuritsky, J.N., S.C. Rastogi, G.A. Faich, J.B. Schorr, J.E. Menitove, R.W. Reilly, and J.R. Bove. 1986. Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotropic III virus, type III. Transfusion 26:205–207.PubMedCrossRefGoogle Scholar
  47. 47.
    Lamberson, H.V., J.A. McMillan, L.B. Weiner, M.L. Williams, D.A. Clark, C.A. McMahon, E.B. Lentz, A.P. Higgins, and N.L. Dock. 1988. Prevention of transfusion-associated cytomegalovirus (CMV) infection in neonates by screening blood donors for IgM to CMV. J of Inf Dis 157:820–823.CrossRefGoogle Scholar
  48. 48.
    Lentz, E.B., N.L. Dock, C.A. McMahon, S.R. Fiesthumel, C.B. Arnold, and H.V. Lamberson. 1988. Detection of antibody to CMV-induced early antigens and comparison with four serologic assays and presence of viruria in blood donors. J of Clin Microbiol 26:133–135.Google Scholar
  49. 49.
    Levy, J.A., A.D. Hoffman, S.M Kramer, J.A. Landis, J.M. Shimabukuro, and L.S. Oshiro. 1984. Isolation of lymphocytoathic retroviruses from San Francisco patients with AIDS. Science 225:840–842.PubMedCrossRefGoogle Scholar
  50. 50.
    Mannucci, P.M., and M Colombo. 1988. Virucidal treatment of clotting factor concentrates. Lancet 2:782–784.PubMedCrossRefGoogle Scholar
  51. 51.
    Minamoto, G.Y., J.W.M. Gold, D.A. Scheinberg, W.D. Hardy, N. Chein, E. Zuckerman, L. Reich, K. Dietz, T. Gee, J. Hoffer, K. Mayer, J. Gabrilove, B. Clarkson, and D. Armstrong. 1988. Infection with human T-cell leukemia virus type I in patients with leukemia. N Eng J Med 318 Google Scholar
  52. 52.
    Mosley, J.W., A.G. Redeker, S.M Feinstone, and R.H. Purcell. 1977. Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N Eng J Med 296:75–78.CrossRefGoogle Scholar
  53. 53.
    Noble, R.C., M.A. Kane, S.A. Reeves, and I. Roeckel. 1984. Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA 252:2711–2715.PubMedCrossRefGoogle Scholar
  54. 54.
    Okochi, K., and H. Sato. 1986. Transmission of adult T-cell leukemia virus (HTLV-1) through blood transfusion and its prevention. AIDS Res 2:S157–S161.PubMedCrossRefGoogle Scholar
  55. 55.
    Okochi, K., H. Sato, and Y. Hinuma. 1984. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 46:245–253.PubMedCrossRefGoogle Scholar
  56. 56.
    Peterman, T.A., K.-J. Lui, D.N. Lawrence, and J.R. Allen. 1987. Estimating the risks of transfusion-associated acquired immune deficiency syndrome and human immunodeficiency virus infection. Transfusion 27:371–374.PubMedCrossRefGoogle Scholar
  57. 57.
    Peterman, T.A., R.L. Stoneburner, J.R. Allen, H.W. Jaffe, and J.W. Curran. 1988. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 259:55–58.PubMedCrossRefGoogle Scholar
  58. 58.
    Poiesz 1980. Detection and isolation of type C retroviruses particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci Vol 77, No 12:7415–7419.PubMedCrossRefGoogle Scholar
  59. 59.
    Popovsky, M.A., L.E. Lindberg, A.L. Syrek, and P.L. Page. 1988. Prevalence of Babesia antibody in a selected blood donor population. Transfusion 28:59–61.PubMedCrossRefGoogle Scholar
  60. 60.
    Robert-Guroff, M, S. Weiss, J. Giron, A.M Jennings, H.M. Ginzburg, I.B. Margolis, W.A. Blattner, and R.C. Gallo. 1986. Prevalence of antibodies to HTLV-I,-II, and-III in intravenous drug abusers from an AIDS endemic region. JAMA 255:3133–3137.PubMedCrossRefGoogle Scholar
  61. 61.
    Robert-Guroff, M, S.H. Weiss, J.A. Giron, A.M Jennings, H.M. Ginzburg, I.B. Margolis, W.A. Blattner, and R.C. Gallo. 1986. Prevalence of antibodies to HTLV-I,-II, and-III in intravenous drug abusers from an AIDS endemic region. JAMA 255:3133–3137.PubMedCrossRefGoogle Scholar
  62. 62.
    Roman, G.C. 1987. Retrovirus-associated myelopathies. Arch Neurol 44:659–663.PubMedCrossRefGoogle Scholar
  63. 63.
    Rosenblatt, J.D., I.S.Y. Chen, and W. Wachsman. 1988. Infection with HTLV-I and HTLV-II: Evolving concepts. Semin. Hematol. 25:230–246.PubMedGoogle Scholar
  64. 64.
    Saah, A.J., H. Farzadegan, R. Fox, P. Nishanian, C.R. Rinaldo, J.P. Phair, J.L. Fahey, T.H. Lee, B.F. Polk, and The Multicenter AIDS Cohort Study. 1987. Detection of early antibodies in HIV infection by enzyme-linked immunosorbent assay, western blot, and radioimmunoprecipitation. J of Clin Microbiol 25:1605–1610.Google Scholar
  65. 65.
    Salahuddin, S.Z., D.V. Ablashi, P.D. Markham, S.F. Josephs, S. Sturzenegger, M. Kaplan, G. Halligan, P. Biberfeld, F.W. Staal, B. Kramarsky, and R.C. Gallo. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596–600.PubMedCrossRefGoogle Scholar
  66. 66.
    Sarngadharan, M.G., M Popovic, L. Bruch, J. Schupbach, and R.C. Gallo. 1984. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 224:506–508.PubMedCrossRefGoogle Scholar
  67. 67.
    Sayers, M.H., P.G. Beatty, and J.H. Hansen. 1986. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III. Transfusion 26:113–115.PubMedCrossRefGoogle Scholar
  68. 68.
    Schorr, J.B., A. Berkowitz, P.D. Cumming, A.J. Katz, and S.G. Sandier. 1985. Prevalence of HTLV-III antibody in American blood donors. N Eng J Med 313:384–385.CrossRefGoogle Scholar
  69. 69.
    Stevens, C.E., R.D. Aach, F.B. Hollinger, J.W. Mosley, W. Szmuness, R. Kahn, J. Werch, and V. Edwards. 1984. Hepatitis B virus antibody in blood donors and the occurrence of Non-A, non-B hepatitis in transfusion recipients. An analysis of the Transmission-Transmitted Viruses Study. Ann of Intern Med 101:733–738.Google Scholar
  70. 70.
    Swenson, S. 1987. Syphilis serology, cytomegalovirus testing and alanine aminotransferase testing, p. 51–90. In M.R. Dixon, and S.S. Ellisor (eds.), Selection of Methods and Instruments for Blood Banks. American Association of Blood Banks, Arlington, VA.Google Scholar
  71. 71.
    Tabor, E., J.H. Hoofnagle, L.F. Barker, G. Tamondong-Pineda, N. Nath, L.A. Smallwood, and R.J. Gerety. 1981. Antibody to hepatitis B core antigen in blood donors with a history of hepatitis. Transfusion 21:366–371.PubMedCrossRefGoogle Scholar
  72. 72.
    Tabor, E., D.R. Jackson, Z. Schaff, P.M. Blatt, and R.J. Gerety. 1984. Additional evidence for more than one agent of human non-A, non-B hepatitis. Transmission and passage studies in chimpanzees. Transfusion 24:224–230.PubMedCrossRefGoogle Scholar
  73. 73.
    Tegtmeier, G.E. 1985. Cytomegalovirus and blood transfusion, p.175–199. In R.Y. Dodd, and L.F. Barker (eds.), Infection, Immunity, and blood transfusion. Alan R. Liss, New York.Google Scholar
  74. 74.
    Tegtmeier, G.E. 1987. Blood transfusion and the transmission of cytomegalovirus, p.87–118. In S.B. Moore (ed.), Transfusion-Transmitted Viral Diseases. American Association of Blood Banks, Arlington, VA.Google Scholar
  75. 75.
    Walker, R.H. 1965. The disposition of STS reactive blood in a transfusion service. Transfusion 5:452–456.PubMedCrossRefGoogle Scholar
  76. 76.
    Wang, J.J.G., S. Steel, R. Wisniewolski, and C.Y. Wang. 1986. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc Natl Acad Sci USA 83:6159–6163.PubMedCrossRefGoogle Scholar
  77. 77.
    Ward, J.W., D.A. Deppe, S. Samson, H. Perkins, P. Holland, L. Fernando, P.M. Feorino, P. Thompson, S. Kleinman, and J.R. Allen. 1987. Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann of Intern Med 106:61–62.Google Scholar
  78. 78.
    Ward, J.W., A.J. Grindon, P.M. Feorino, C. Schable, M Parvin, and J.R. Allen. 1986. Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III. JAMA 256:357–361.PubMedCrossRefGoogle Scholar
  79. 79.
    Ward, J.W., S.D. Holmberg, J.R. Allen, D.L. Cohn, S.E. Critchley, S.H. Klcinman, B.A. Lenes, O. Ravenholt, J.R. Davis, M.G. Quinn, and a. l. et. 1988. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N. Engl. J. Med. 318:473–478.PubMedCrossRefGoogle Scholar
  80. 80.
    Williams, A.E., CT. Fang, D.J. Slamon, B.J. Poiesz, S.G. Sandler, W.F. Darr, G. Shulman, E.I. McGowan, D.K. Douglas, R.J. Bowman, F. Peetoom, S.H. Kleinman, B. Lenes, and R.Y. Dodd. 1988. Seroprevalence and epidemiological correlates of HTLV-1 infection in U.S. blood donors. Science 240:643–646.PubMedCrossRefGoogle Scholar
  81. 81.
    Winston, D.J., W.G. Ho, L. Cheng-Hsien, K. Bartoni, MD. Budinger, R.P. Gale, and R.E. Champlin. 1987. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann of Intern Med 106:12–18.Google Scholar
  82. 82.
    Wolinsky, S., C. Rinaldo, H. Farzadegan, P. Gupta, R. Kaslow, D. Immagawa, J. Chmiel, J., Phair, J. Kwok, and J. Sninsky. 1988. Polymerase chain reaction (PCR) detection of HIV provirus before HIV seroconversion. Abstracts: IV International Conference on AIDS. 1:137.(Abstract)Google Scholar
  83. 83.
    Yeager 1983. Sequelae of maternally derived cytomegalovirus infections in premature infants. J of Pediatrics. 102:918–922.CrossRefGoogle Scholar
  84. 84.
    Zuck, T.F. 1987. Greetings — a final look back with comments about a policy of a zero-risk blood supply. Transfusion 27:447–448.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Roger Y. Dodd
    • 1
  1. 1.Jerome H. Holland LaboratoryAmerican Red CrossRockvilleUSA

Personalised recommendations